Literature DB >> 24730233

Advances in stimuli responsive nanobiomaterials for cancer therapy.

Kaarunya Sampathkumar, Shylaja Arulkumar, Murugan Ramalingam.   

Abstract

Cancer has become one of the major reasons for disease mortality with drastic increase of death rate in recent years. The reason for most of these deaths is due to the inefficacy and failure of the current methods of treatments or due to the unavailability of treatment options. Even after extensive research that has been carried out in the field, there is no gold standard in cancer therapy. With the advancement of the field of nanomedicine and materials science, many research works are being aimed at developing micro and nanocarriers for site-specific delivery of anticancer drugs. As a further advancement in the field, smart carriers, based on nanobiomaterials, which respond to various external and internal stimuli and act locally are being developed to improve the efficacy of current treatments. These smart nanobiomaterials act as carriers for not only anticancer drugs but also for gene and other biomolecules. Keeping the importance and advancement of smart carrier anticancer drug delivery system (AcDDS) in view, this review focuses on stimuli responsive nanobiomaterials that are currently being studied for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24730233     DOI: 10.1166/jbn.2014.1778

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  4 in total

1.  Temperature-triggered phase separation of a hydrophilic resilin-like polypeptide.

Authors:  Linqing Li; Tianzhi Luo; Kristi L Kiick
Journal:  Macromol Rapid Commun       Date:  2014-11-26       Impact factor: 5.734

Review 2.  Nanotechnology applications in thoracic surgery.

Authors:  Sophie C Hofferberth; Mark W Grinstaff; Yolonda L Colson
Journal:  Eur J Cardiothorac Surg       Date:  2016-02-02       Impact factor: 4.191

3.  Delivery of vincristine sulfate-conjugated gold nanoparticles using liposomes: a light-responsive nanocarrier with enhanced antitumor efficiency.

Authors:  Ying Liu; Man He; Mengmeng Niu; Yiqing Zhao; Yuanzhang Zhu; Zhenhua Li; Nianping Feng
Journal:  Int J Nanomedicine       Date:  2015-04-22

4.  pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.

Authors:  Yiwen Wang; Fei Qin; Haina Tan; Yan Zhang; Miao Jiang; Mei Lu; Xin Yao
Journal:  Int J Nanomedicine       Date:  2015-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.